2013
$71M
from 9 investors over 9 rounds
MabPlex International Co., Ltd. raised $71M on June 8, 2020
Investors: Acusea/Huiyuan Capital, OrbiMed Advisors and Sunshine Insurance Group
MabPlex International Co., Ltd. raised $59M on January 17, 2019
Investors: Apollomics, ANTAGENE, 深圳裕策生物科技有限公司, 澳斯康生物制药Thousand Oaks Biopharmaceuticals, Shenzhen Capital Group Co., Ltd and Apic Bio, Inc.